 |
 |
 |
 |
 |
 |
 |
||||
|
||||||||||
 Construction, Characterization and PathologyPolypeptide Growth Factors and Prostate CancerAndrogen Axis and Prostate CancerImmunotherapyPre-Clinical TrialsReviews |
1. Wechter, W.J., Leipold, D.D., Murray, D. Jr., Quiggle, D., McCracken, J.D., Barrios, R.S. and Greenberg, N.M. 2000. E-7869 (R-flubriprofen) inhibits progression of prostate cancer in the TRAMP model. Cancer Research 60: 2203-2208. [PDF] 2. Raghow, S., Steakley, M., Greenberg, N. and Steiner, M.S. 2000. Efficacious Chemoprevention of Primary Prostate Cancer by Flutamide in an Autochthonous Transgenic Model. Cancer Res 60: 4093-4097. [PDF] 3. Gupta, S., Ahmad, N., MacLennan, G.T., Greenberg, N.M. and Mukhtar, H. 2000. Chemoprevention of prostate carcinogenesis by alpha-diflouromethylornithine in TRAMP mice. Cancer Research 60: 5125-5133. [PDF] 4. Shariat, S.F., Desai, S., Song, W., Khan, T., Xiao, J., Nguyen, C., Foster, B.A., Greenberg, N., Spencer, D.M., and Slawin, K.M. 2001. Adenoviral mediated transfer of inducible caspases: a novel "death switch" gene therapeutic approach to prostate cancer. Cancer Research 61: 2562-2571.[PDF] 5. Mentor-Marcel, R., Lamartiniere, C., Eltoum, I.-E, Greenberg, N.M., and Elgavish, A. 2001. Genestein in the diet reduces the incidence of prostate tumors in a transgenic mouse(TRAMP). Cancer Research 61: 6777-6782. [PDF] 6. Arap W, Haedicke W, Bernasconi M, Kain R, Rajotte D, Krajewski S, Ellerby HM, Bredesen DE, Pasqualini R, Ruoslahti E. 2002. Targeting the prostate for destruction through a vascular address. Proc Natl Acad Sci (USA) 99(3):1527-1531. [PDF] 7. Shah, A.H., Tabayoyong, T., Kundu, S.D., Kim, S-J., Parijs, L.K., Liu, V.C., Kwon, E., Greenberg, N.M. and Lee, C. 2002. Suppression of tumor metastasis by blockade of transforming growth factor ß signaling in bone marrow cells through a retroviral-mediated gene therapy in mice. Cancer Research 62:7135-7138. [PDF] 8. Huss, W.J., Barrios and Greenberg, N.M. 2003. SU5416 Impairs Angiogenesis to Induce Prostate Cancer-specific Apoptosis. Molecular Cancer Therapeutics 2:611-616.[PDF] |
